J
José A. Luchsinger
Researcher at Columbia University
Publications - 267
Citations - 21579
José A. Luchsinger is an academic researcher from Columbia University. The author has contributed to research in topics: Dementia & Risk factor. The author has an hindex of 68, co-authored 231 publications receiving 19153 citations. Previous affiliations of José A. Luchsinger include Columbia University Medical Center & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Urban-Dwelling Community Members’ Views on Biomedical Research Engagement:
TL;DR: A qualitative analysis was conducted to explore community members’ overall understanding and experience with biomedical research engagement using four focus group sessions with 30 urban-dwelling community members and five main themes were identified.
Book ChapterDOI
Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
TL;DR: More longitudinal studies are needed with concurrent assessment of metabolic factors and AD biomarkers in order to improve the opportunity to assess causality, and Ideally, AD biomarker research should be integrated into clinical trials of interventions that affect metabolic factors.
Journal ArticleDOI
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics.
José A. Luchsinger,Priya Palta,Brady Rippon,Luisa Soto,Fernando Ceballos,Michelle Pardo,Krystal K. Laing,Kay C. Igwe,Aubrey Johnson,Zeljko Tomljanovic,Hengda He,Christiane Reitz,William C. Kreisl,Qolamreza R. Razlighi,Jeanne A. Teresi,Herman Moreno,Adam M. Brickman +16 more
TL;DR: Higher amyloid and tau burden in late middle age is followed by increased neurodegeneration and cognitive decline in females as compared with males as well as males to explain the reported higher dementia risk in elderly females compared to males.
Journal ArticleDOI
Apolipoprotein E genotype and in vivo amyloid burden in middle-aged Hispanics
Priya Palta,Brady Rippon,Christiane Reitz,Hengda He,Greysi Sherwood,Fernando Ceballos,Jeanne A. Teresi,Qolamreza R. Razlighi,Herman Moreno,Adam M. Brickman,José A. Luchsinger +10 more
TL;DR: Middle-aged Hispanic APOE ε4 carriers have higher in vivo brain amyloid burden compared with noncarriers, as reported in non-Hispanics.
Journal ArticleDOI
Mild Cognitive Dysfunction Does Not Affect Diabetes Mellitus Control in Minority Elderly Adults
Priya Palta,Priya Palta,Sherita Hill Golden,Jeanne A. Teresi,Walter Palmas,Ruth S. Weinstock,Steven Shea,Jennifer J. Manly,Jennifer J. Manly,José A. Luchsinger +9 more
TL;DR: To determine whether older adults with type 2 diabetes mellitus and cognitive dysfunction have poorer metabolic control of glycosylated hemoglobin, systolic blood pressure, and low‐density lipoprotein cholesterol than those without cognitive dysfunction, an apples-to- apples comparison study is conducted.